The pharma market is the region’s most dynamic, according to regional players. The pharma spending per capita between 2002 and 2006 witnessed a 36% increase in
Around 89% of the pharmaceutical market is supplied by imports.
At present more than 70% of the expenditure on drugs is directed to original, or branded products.
The quality of drug production has risen since the enforcement of GMP on 1st January 2004. However, the number of local drug producers fell from 71 to 31 as a result. Top local producers are: Terapia Ranbaxy, Zentiva, Antibiotice, Actavis, Gedeon Richter Romania SA, LaborMed, Biofarm.
A number of acquisitions have taken place in the market, including that of Sicomed in September 2005, whereby Zentiva of the